DFT Calculations and In silico Study of Chlorogenic, Ellagic and Quisqualic acids as Potential Inhibitors of SARS-CoV-2 Main Protease Mpro

被引:6
|
作者
Shahab, Siyamak [1 ,2 ,3 ]
Kaviani, Sadegh [4 ]
Sheikhi, Masoome [5 ]
Almodarresiyeh, Hora Alhosseini [6 ]
Al Saud, Sultan [1 ,3 ]
机构
[1] Belarusian State Univ, ISEI BSU, Minsk, BELARUS
[2] Natl Acad Sci Belarus, Inst Phys Organ Chem, 13 Surganov Str, Minsk 220072, BELARUS
[3] Natl Acad Sci Belarus, Inst Chem New Mat, 36 Skarina Str, Minsk 220141, BELARUS
[4] Ferdowsi Univ Mashhad, Fac Sci, Dept Chem, Mashhad, Razavi Khorasan, Iran
[5] Islamic Azad Univ, Gorgan Branch, Young Researchers & Elite Club, Gorgan, Golestan, Iran
[6] Meybod Univ, Sch Engn, Dept Mat Sci & Engn, Meybod 8961699557, Yazd, Iran
来源
BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY | 2022年 / 12卷 / 01期
关键词
SARS-CoV-2 main protease M-pro; DFT; molecular docking; chlorogenic; Ellagic and Quisqualic acids; pharmacokinetic properties; COFFEE; METABOLITES; DERIVATIVES; DISCOVERY; TRANSPORT; UV/VIS; HUMANS;
D O I
10.33263/BRIAC121.061073
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
In the present work, at first, density functional theory calculations were performed to investigate the molecular structure of the Chlorogenic, Ellagic, and Quisqualic acids by CAM-B3LYP/MidiX level of theory. A detail of quantum molecular descriptors of the title compounds such as ionization potential (IP) and Electron Affinities (EA), Hardness (eta), Softness (S), Electronegativity (mu), Electrophilic Index (omega), Electron Donating Power (omega-), Electron Accepting Power (omega+) and Energy Gap (Eg) have been calculated. Pharmacokinetic properties of the title compounds and their bioactivity were investigated. In the following, a molecular docking study was carried out to screen for an effective available compound that may work as a strong inhibitor for the SARS-CoV-2 main protease Mpro. The binding energy between SARS-CoV-2 main protease Mpro and title organic acids showed a good binding affinity. Therefore, the Chlorogenic, Ellagic, and Quisqualic acids can be used for potential application against the SARS-CoV-2 main protease Mpro.
引用
收藏
页码:61 / 73
页数:13
相关论文
共 50 条
  • [41] Drug repurposing and computational modeling for discovery of inhibitors of the main protease (Mpro) of SARS-CoV-2
    Silva, Jose Rogerio A.
    Kruger, Hendrik G.
    Molfetta, Fabio A.
    RSC ADVANCES, 2021, 11 (38) : 23450 - 23458
  • [42] Targeting allosteric pockets of SARS-CoV-2 main protease Mpro
    Bhat, Zahoor Ahmad
    Chitara, Dheeraj
    Iqbal, Jawed
    Sanjeev, B. S.
    Madhumalar, Arumugam
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (14): : 6603 - 6618
  • [43] In Silico Study of Coumarins and Quinolines Derivatives as Potent Inhibitors of SARS-CoV-2 Main Protease
    Yanez, Osvaldo
    Osorio, Manuel Isaias
    Uriarte, Eugenio
    Areche, Carlos
    Tiznado, William
    Perez-Donoso, Jose M.
    Garcia-Beltran, Olimpo
    Gonzalez-Nilo, Fernando
    FRONTIERS IN CHEMISTRY, 2021, 8
  • [44] In silico screening of potential inhibitors from Cordyceps species against SARS-CoV-2 main protease
    Deshmukh, Niketan
    Talkal, Reshma
    Lakshmi, Bhaskaran
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, : 4395 - 4411
  • [45] An Integrative in Silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main Protease
    Djokovic, Nemanja
    Ruzic, Dusan
    Djikic, Teodora
    Cvijic, Sandra
    Ignjatovic, Jelisaveta
    Ibric, Svetlana
    Baralic, Katarina
    Buha Djordjevic, Aleksandra
    Curcic, Marijana
    Djukic-Cosic, Danijela
    Nikolic, Katarina
    MOLECULAR INFORMATICS, 2021, 40 (05)
  • [46] Computational Prediction of Potential Inhibitors of the Main Protease of SARS-CoV-2
    Abel, Renata
    Ramos, Maria Paredes
    Chen, Qiaofeng
    Perez-Sanchez, Horacio
    Coluzzi, Flaminia
    Rocco, Monica
    Marchetti, Paolo
    Mura, Cameron
    Simmaco, Maurizio
    Bourne, Philip E.
    Preissner, Robert
    Banerjee, Priyanka
    FRONTIERS IN CHEMISTRY, 2020, 8
  • [47] Computational Determination of Potential Inhibitors of SARS-CoV-2 Main Protease
    Son Tung Ngo
    Ngoc Quynh Anh Pham
    Ly Thi Le
    Duc-Hung Pham
    Vu, Van V.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2020, 60 (12) : 5771 - 5780
  • [48] Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach
    Enmozhi, Sukanth Kumar
    Raja, Kavitha
    Sebastine, Irudhayasamy
    Joseph, Jerrine
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (09): : 3092 - 3098
  • [49] Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease
    Motyan, Janos Andras
    Mahdi, Mohamed
    Hoffka, Gyula
    Tozser, Jozsef
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [50] Targeting the SARS-CoV-2 Main Protease: In Silico Study Contributed to Exploring Potential Natural Compounds as Candidate Inhibitors
    Ounissi, Mourad
    Rachedi, Fatma Zohra
    JOURNAL OF COMPUTATIONAL BIOPHYSICS AND CHEMISTRY, 2022, 21 (06): : 663 - 682